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Summary
Background: To evaluate efﬁcacy and cost-effectiveness of a 
plant-derived wound dressing (ONE), a mixture of hypericum 
oil (Hypericum perforatum L.) and neem oil (Azadirachta indi-
ca A. Juss.), in scalp wounds with exposed bone. Patients and 
Methods: All patients with scalp wounds with exposed bone, 
following the excision of skin tumors, and treated with ONE in 
2011 were included. Time of healing, wound size, area of ex-
posed bone, ease of handling, pain, and complications were 
evaluated. Costs of dressings and nursing time were com-
pared with those cited in literature for other treatment modali-
ties. Results: Fifteen consecutive patients with a mean age of 
76.87 ± 10.3 years (59–90 years) were analyzed. The mean 
wound size was 10.9 ± 6.84 cm2 (0.4–22.6 cm2) with 4.8 ± 5.9 
cm2 (0.3–20.7 cm2) of exposed bone. The time of complete 
healing by secondary intention was 8.1 (4–20) weeks. Rapid 
formation of granulation tissue was observed which after 4 
weeks covered the entire exposed bone surface in 11 of 15 
cases (73%). Dressing change was simple with no pain report-
ed; no infections or other complications occurred. Using ONE 
for a mean healing time of 56.7 days resulted in mean costs of 
EUR 423.73, which is substantially lower than those published 
for fascia lata, negative pressure therapy, or collagen matrix 
followed by skin grafting (EUR 1,612.82, EUR 4,411.80 and EUR 
1,503.72, respectively). Conclusion: This retrospective, non-
controlled analysis supports ONE as a simple-to-use and safe 
treatment option for scalp wounds with exposed bone. Treat-
ment costs compare favorably to those published for other 
treatment modalities.
Schlüsselwörter
Wundverband · Neemöl · Johanniskrautöl · 
Skalpwunden mit freiliegendem Knochen · 
Sekundäre Wundheilung
Zusammenfassung
Hintergrund: Diese retrospektive, nicht-kontrollierte Analyse 
untersucht die Frage, ob durch Tumorexzision entstandene 
Skalpwunden mit freiliegenden Knochen mit einem pﬂanz-
lichen Wundtherapeutikum (ONE), bestehend aus Johannis-
krautöl (Hypericum perforatum L.) und Neemöl (Azadirachta 
indica A. Juss.), mittels sekundärer Wundheilung kosteneffek-
tiv behandelt werden können. Patienten und Methoden: Einge-
schlossen wurden alle Patienten mit einer Skalpwunde mit frei-
liegendem Knochen als Folge einer Tumorexzision, die in 2011 
mit ONE behandelt wurden. Dabei wurden die Abheilungsdau-
er, die Veränderung der Wundﬂäche, die Fläche des freiliegen-
den Knochens, Schmerzen und Einfachheit der Anwendung 
untersucht. Die verursachten Kosten wurden mit anderen Be-
handlungsmaßnahmen verglichen, die sich aus der Literaturre-
cherche ergeben haben. Resultate: Die Patienten waren durch-
schnittlich 76,87 ± 10,3 Jahre (59–90 Jahre) alt. Die Skalpwunden 
hatten eine durchschnittliche Wundgröße von 10,9 ± 6,84 cm2 
(0,4–22,6 cm2) mit durchschnittlich 4,8 ± 5,9 cm2 (0,3–20,7 cm2) 
freiliegendem Knochen. Die Zeitdauer bis zum kompletten 
Wundverschluss durch Sekundärheilung betrug 8,1 Wochen 
(4–20 Wochen). Es konnte eine rasche Bildung von Granulati-
onsgewebe beobachtet werden, was bei 11 von 15 (73%) Fällen 
innerhalb von 4 Wochen zu einer kompletten Deckung des frei-
liegenden Knochens führte. Der Verbandswechsel war einfach 
und schmerzfrei; es gab keine Anzeichen für eine Infektion oder 
andere unerwünschte Wirkungen. Die durchschnittlichen Be-
handlungskosten betrugen 423,73 EUR und lagen damit deut-
lich niedriger als die aus der Literatur bekannten Kosten für 
Lappenplastik (1612,82 EUR), Unterdrucktherapie (4411,80 EUR) 
oder Kollagen-Matrix mit nachfolgender Deckung durch Spalt-
haut (1503,72 EUR). Schlussfolgerung: Diese retrospektive, 
nicht-kontrollierte Analyse bestätigt, dass ONE eine einfach an-
zuwendende, kostengünstige und effektive Behandlungsoption 
von Skalpwunden mit freiliegendem Knochen ist.
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Neuwied, Germany) or an absorbent dressing (Primapore, Smith and 
Nephew, Hamburg, Germany). The choice of the secondary dressing was 
based on the moisture levels of the wound. Necrotic and fibrinous tissue 
was removed with a curette or tweezers and scissors.
Treatment with ONE was maintained up to complete closure of the 
wound which was defined as 100% epithelialization. The treatment pe-
riod was defined as the time between the first application of the dressing 
and complete wound closure. All of the patients provided informed con-
sent for their data to be submitted for publication.
Each patient attended the outpatient clinic at least once every 2 weeks 
to have the wound checked and dressed by the clinic nurse. Daily dressing 
changes were carried out at the patients’ homes, either by a family mem-
ber or a community nurse. Before starting treatment and at each visit to 
the outpatient clinic, the wound was photographed, and the wound sur-
face area and surface area of exposed bone were measured from the pho-
tographs using special software (synedra View). At each follow-up visit, 
pain, clinical side effects, and signs of infection were recorded. 
Material and labor costs were assessed retrospectively by recording 
from the clinic’s patient notes, in particular the materials used at dressing 
change, the number of clinic visits made, and the time taken to perform 
the dressing changes. At every clinic visit, patients were asked about the 
number of dressing changes and time taken for the dressing changes at 
home. The actual units of ONE used were recorded, and the costs were 
allocated to each dressing change based on the number of spray dis-
charges per unit as advised by the manufacturer. Labor costs were allo-
cated for clinic visits using the relevant Swiss TARMED tariff and for the 
home-based dressing changes assuming the labor cost per hour of the 
community nurse. An average of clinic visits and home dressing changes 
for all 15 patients was taken from the records.
After wound healing had occurred, patients were followed up with a 
clinical visit or by telephone in April 2012 to confirm the persistence of 
healing and the cosmetic outcome as assessed by them. The cosmetic re-
sult was not assessed by use of a validated scar or cosmesis scale.
Results
Clinical Outcomes
In the reviewed period, all 15 patients with postoperative 
scalp wounds with exposed calvarian bone following the exci-
sion of skin tumors were treated with ONE. The patients’ mean 
age was 76.87 ± 10.3 years (59–90 years). In 7 patients, the ex-
cised tumors were squamous cell carcinomas (SCC), in 6 basal 
cell carcinomas (BCC). The diagnoses of the remaining 2 pa-
tients were lentigo maligna (n = 1) and atypical ﬁbroxanthoma 
(AFX; n = 1; table 1). All of the wounds were on the scalp. Sec-
ondary diagnoses included arterial hypertension (n = 6), aller-
gies (n = 1), and non-skin malignant tumors (n = 2). The mean 
surface area of the wound on presentation was 10.9 ± 6.84 cm2 
(0.4–22.6 cm2). All of the wounds had bone exposed, and the 
mean surface area of exposed bone was 4.8 ± 5.9 cm2 (0.3–20.7 
cm2). The wounds of all 15 patients were healed by secondary 
intention with no other intervention (table 1). The mean treat-
ment period until 100% epithelialization of the wounds was 
8.1 ± 4.4 weeks (range 4–20 weeks; table 1). The mean reduc-
tion in wound surface area after 4 weeks of treatment was 
7.6 cm2, from a mean of 10.9–3.3 cm2 (a reduction of 70%), and 
the mean reduction of the surface area of exposed bone was 
4.4 cm2, from a mean of 4.8–0.4 cm2 (92% reduction; ﬁgs. 1 and 2).
Introduction
Deep scalp wounds with the exposure of calvarian bone 
present the challenge of closing the periosteal defect as the 
exposed bone presents a very hostile environment for wound 
healing due to insufﬁcient vascularization. Surgical options, 
such as grafting and skin substitutes [1, 2], are limited due to 
the minimal vascularization of the bone surface and therefore 
usually require removal or drilling holes in the tabula externa 
[3]. These procedures offer fast solutions, but usually require 
the patients to be able to undergo anesthesia. Furthermore, 
they are expensive which is also true for other advanced meth-
ods, such as negative pressure wound therapy (NPWT) or col-
lagen matrix. Their use must be weighed against the level of 
risk and resources available. Healing of wounds with exposed 
bone by secondary intention is usually very slow and typically 
involves a moist wound-healing environment [4]. Although 
traditionally regarded as painful and risking infection, this has 
not been conﬁrmed in the published literature [5, 6].
A new plant-derived wound therapeutic in spray form 
available on the Swiss market (1 Primary Wound Dressing® 
(ONE), Phytoceuticals AG, Zurich, Switzerland) was evaluat-
ed in our clinic on postoperative scalp wounds with exposed 
bone. The spray consists of a mixture of hypericum oil (Hy-
pericum perforatum L.) and neem oil (Azadirachta indica A. 
Juss.), designed to create a moist wound-healing environment, 
with an oil layer preventing the secondary dressing from ad-
hering to the wound. It is thought to have an antimicrobial ef-
fect [7]. Its spray application, providing easy use by patients as 
well as clinicians, and its action of supporting the appropriate 
moisture balance of the wound suggest it as a useful alterna-
tive to existing treatments.
An initial retrospective study [8] was carried out on 9 out-
patients with postoperative scalp wounds with exposed calvar-
ian bone following excision of skin tumors, at the Department 
of Dermatology of the University Hospital of Zurich, Switzer-
land, from January to July 2011. The promising results with fast 
induction of granulation tissue led to interest in a larger series 
and a more detailed analysis of the costs involved with differ-
ent treatment modalities.
Methods
A retrospective review was performed on all patients with postopera-
tive scalp wounds with exposed calvarian bone following excision of skin 
tumors, at the Department of Dermatology of the University Hospital of 
Zurich, Switzerland, from January to December 2011.
All wounds had initially been treated with a split thickness skin graft 
which did not take due to insufficient blood supply after removal of the 
periosteum or desiccation of the tissue in the healing process. Once the 
exposed bone was apparent in the healing process, the wounds were man-
aged with the wound dressing (ONE), applied daily on the wound and 
periwound skin. Saline solution was used in 8% of dressing changes; no 
other antiseptic was applied. The wound and periwound skin was then 
covered with a nonwoven gauze (Vliwasoft®, Lohmann and Rauscher, 
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In 7 patients (47% of the sample), the area of exposed bone 
was completely covered (100%) by granulation tissue after 2 
weeks; 6 of these patients had surface areas of exposed bone at 
the start of treatment < 2 cm2, but one had a surface area of 6.9 
cm2; this wound bed showed rapid granulation. At 4 weeks, the 
exposed bone had been completely covered by granulation tis-
sue in 11 patients (73%); the remaining 4 patients had areas of 
exposed bone of > 3 cm2 at the start of treatment. 
No patient reported severe pain during the entire treatment 
period nor were dressing changes reported to be painful. No 
wound was assessed as showing clinical symptoms of superﬁ-
cial or deep infection. None of the patients showed signs of 
allergic reactions, and no other side effects were observed. Pa-
tients came for a follow-up visit in April/May 2012 or could be 
contacted by telephone. All of them conﬁrmed persistence of 
healing and none reported problems or wound dehiscence. 
One patient reported slight itching at the wound site and one 
an occasional slight feeling of tension in the scar. All patients 
reported a satisfactory cosmetic outcome of treatment with 
ONE.Ta
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Fig. 1. 63-year-old 
man with scalp 
wound after tumor 
excision with ex-
posed bone following 
graft failure. Healing 
process after 3 weeks 
with granulation 
 tissue covering the 
bone and after  
7 weeks with fully 
epithelialized wound.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
6/
3/
20
16
 2
:3
0:
21
 P
M
Forsch Komplementmed 2014;21:88–93Plant-Derived Wound Therapeutic for  
Post-Surgical Scalp Wounds
91
Costs of Treatment
On the average, there were 8 visits to the outpatient clinic 
and thus just as much dressing changes. The average number 
of dressing changes taking place at home was 51.4. 12 patients 
(80%) had home dressing changes carried out by a family 
member and 3 patients by a community nurse. Costs were al-
located to the time of the community nurse but not to that of 
the family member. The tariff for labor costs at the outpatient 
clinic included items with a unit price < CHF 3 (EUR ca. 2.50), 
such as gloves, sterilization of instruments, cotton swabs, and 
simple secondary dressing. 
The total mean per capita cost for treatment with ONE at the 
outpatient clinic and for dressing changes carried out by the 
community nurse at home was CHF 961.90 (EUR ca. 800) and for 
treatment by the outpatient clinic with home dressing changes 
done by a family member CHF 395.90 (EUR ca. 330). This gave 
a range of average weekly costs of EUR 40.70–98.80 per capita 
(see table 2 and 3 for explanation of the calculation of costs).
The total cost for all 15 patients was calculated by adding 
the total cost for the 3 patients who had dressings changed by 
nurses both at the outpatient clinic and at home, and the total 
costs for the 12 patients who had dressings changed by nurses 
at the outpatient clinic, but by family members at home. This 
total was then divided by the total number of patients to arrive 
at the mean per capita cost shown in table 4.
Fig. 2. 90-year-old 
man with scalp 
wound after tumor 
excision with 
exposed bone 
following graft 
failure. Healing 
process after 2 weeks 
with some granula-
tion visible on the 
bone, and after 4 
weeks with the entire 
bone surface covered 
by granulation tissue.
postoperative
2 weeks
4 weeks
At outpatient clinic – dressing change performed by clinic nurse
Average time for dressing change in the outpatient Clinic, min  10
Cost per min, CHF   2.4
Labor costs for each dressing change, CHF  24
Cost of ONE per dressing change, CHF   3.0
Total costs per dressing change in the outpatients clinic, CHF  27
At home – dressing change performed by community nurse
Average time for dressing change, min   5
Cost per min, CHF   2.2
Labor costs for each dressing change, CHF  11
Cost of ONE per dressing change, CHF   3.0
Primapore Dressing (7.5 × 5)   0.5
Total costs per dressing change at home, CHF  14.5
Average number of dressing changes at the hospital   8
Average number of dressing changes at home  51.4
Total cost of average wound management, CHF 961.9
Table 2. Average cost of care with dressing 
changes at home performed by community 
nurse
Table 3. Average cost of care with dressing changes at home performed 
by family member
Average number of dressing changes in the hospital (USZ) 8
Average number of dressing changes at home 51.4
Calculation of total costs (hospital costs 8 changes × CHF 27)
Home costs (materials only – no labor)
ONE, CHF
Primapore Plaster, CHF
Total materials, CHF (3.5 × 51.4 changes) 
216.0
3
0.5
179.90
Total costs of average wound management, CHF 395.90
USZ = University Hospital Zurich
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or removing the tabula externa of the calvarian bone. The lat-
ter usually requires general anesthesia.
NPWT may be used to support secondary intention healing 
or graft take [11–13]. Tissue-engineered skin substitutes offer 
fast cover of scalp wounds, but also require a vascularized 
wound bed [14]. Both interventions are expensive and may 
have limited availability in such patients.
Secondary intention healing has been considered to be 
painful, risking a high infection rate and requiring extensive 
care, but this is not substantiated in literature. Comorbidities 
or side effects of oncologic treatments may further delay tissue 
regeneration. Inhoff et al [9] comment that healing by second-
ary intention implies a longer treatment duration and thus 
greater discomfort for the patient. Furthermore, the authors 
state that at a cost of about EUR 70 per week, any advantage 
due to savings on expensive materials (fascia lata, Integra, 
vacuum-assisted closure) is lost. 
Contrary to the comments above, the extension of our case 
series by 6 patients to a total of 15 supports that secondary 
intention healing does not inevitably entail infection, pain, or 
unsatisfactory cosmetic results. None of the 15 patients had 
clinical signs of infection and none of them reported severe 
pain. The weekly checks at the outpatient clinic gave the op-
portunity for visual checking of tumor recurrence. By week 2, 
areas of exposed bone in 7 of 15 (47%) patients had already 
been covered by granulation tissue, thus signiﬁcantly and 
quickly reducing the risk of complications in the bone, with 
areas of exposed bone fully covered in 11 of 15 (73%) cases by 
week 4. The use of ONE therefore contributed to a signiﬁcant 
reduction of risk for the studied cohort, and avoided further 
scarring of donor sites requiring ﬂap or skin-graft techniques. 
Paucity of infectious complications is also reﬂected in the lit-
erature. For instance, Becker et al. [5] reported no infection in 
Comparison with a Historical Review of Costs Associated 
with the Use of Alternative Therapies for Closing Complex 
Scalp Wounds 
The costs derived from the retrospective study were com-
pared with costs reported by Inhoff et al. [9], which were as-
sociated with the coverage of exposed bone achieved by in-
ﬁlling with fascia lata, NPWT, or a collagen matrix dressing 
prior to ﬁnal grafting. Inhoff et al. reviewed 52 cases treated at 
the Dermatology Department of the University Hospital of 
Mannheim, Germany, with a 2-stage process of tumor excision, 
conditioning of the wound bed to promote granulation in 
preparation for grafting, and then grafting. After tumor exci-
sion, 5 wounds were treated with processed allogenic fascia 
lata, 14 with NPWT, and 33 with a collagen matrix. The mean 
costs per wound reported for these procedures for the prepa-
ration of the wound bed were compared with the mean costs 
of our current study. Inhoff et al. did neither report the indi-
vidual wound surface areas nor the individual areas of exposed 
bone, so no comparison could be made with the cost to achieve 
granulation. Inhoff et al. also did not report the incidence of 
infection or other complications (table 4).
Discussion
In the treatment of scalp wounds, exposure of the calvarian 
bone presents particular challenges [6]. Speedy closure with a 
ﬂap and/or skin graft is commonly considered the preferred 
treatment [10], although this may involve problems arising 
from donor site mobility, duration of the surgical procedure, 
and later on absence of hair regrowth, especially in free ﬂap 
reconstruction. Skin grafts require a vascularized wound bed 
which, in case of exposed bone, usually requires drilling holes 
Fascia lata Vacuum-assisted  
closure
Collagen matrix ONE 
Patients, N 5 14 33 15
Mean length of outpatient care after  
tumor excision, days
48.1 34.7 21.4 56.7 
Mean outpatient dressing changes, n 15.3 10.7 6.1 8 at clinic
51.4 at home by family 
member or community 
nurse
Mean cost of outpatient dressing  
changes, EUR 
230.73 2,989.42 72.95 423.73*
Mean length of second hospitalization  
for grafting, days
5.2 5.3 5.3 0 (no graft carried out)
Mean cost of hospitalization, EUR 1,222.68 1,246.19 1,246.19 0 
Mean surgical cost, EUR 159.41 176.19 184.58 0
Mean duration of treatment after  
tumor excision, days
53.3 40 26.7 56.7 
Mean total cost, EUR 1,612.82 4,411.80 1,503.72 423.73
Mean total cost per day, EUR 30.26 110.30 56.32 7.47
*12 patients had home dressing changes carried out by family members and 3 by community nurses.
Table 4. Compari-
son of reported costs 
of wound bed prepa-
ration and closure 
with grafting as re-
ported by Inhoff et al 
[9] with costs associ-
ated with wound bed 
preparation and clo-
sure under treatment 
with ONE
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EUR 423.73, as compared to EUR 1,503.72–4,411.80 using ad-
vanced methods such as NPWT or skin substitutes, indicates a 
substantial potential for cost saving in this patient population. 
Limitations
The study includes only a small number of patients recruited 
from a single center with data analyzed retrospectively. Cos-
metic outcomes were not assessed visually using a recognized 
validated tool, and follow-up took place with a random distri-
bution of time since wound closure. Full data on wound surface 
area and speed of granulation over bone was not available 
from the study by Inhoff et al. [9], so that only an illustration of 
comparative cost could be made. Even if indirect comparison 
with published data on the management and costs of wound 
treatments can only give a general indication of comparative 
beneﬁt, the characteristics of the wounds included in this study 
are similar to those reported in other published trials. Thus it 
can be concluded that the results compare favorably, both clini-
cally and economically, with those from the literature. 
Conclusion
The results of this extended retrospective review continue 
to indicate that the plant-derived wound spray ONE is clini-
cally effective for scalp wounds which show exposed bone, and 
that it may represent a cost-effective alternative to other treat-
ment options. Controlled studies, with a larger population, are 
still required to further assess the effectiveness and economy 
of this wound spray.
Disclosure Statement
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38 cases, and Snow et al. [6] assessed a very low rate of soft tis-
sue infection (2.7%) in 115 cases. The patients’ responses to 
the telephone survey indicated satisfaction with the cosmetic 
results. This is also supported by the literature [15]. Gohari et 
al. [16] compared secondary intention healing with the use of 
tissue-engineered skin substitutes and showed patient satisfac-
tion with cosmetic outcome, equally positive in both groups.
The present review of 15 patients continues to support that 
the plant-derived wound dressing ONE is a powerful aid to the 
healing process of post-surgical scalp wounds with exposed 
bone. In 11 of 15 patients (73%), the bone was completely cov-
ered by granulation tissue after 4 weeks of treatment, and 6 of 
these wounds were epithelialized after 6 weeks. With the excep-
tion of one patient whose complete wound coverage took 20 
weeks, there seems to be a clear trend to shorter healing times 
as compared to the published literature, with the formation of 
granulation tissue over exposed bone in 14 of 15 cases within 6 
weeks, and a mean healing time of 8.1 weeks. Direct comparison 
of healing times with other studies is difﬁcult, as methodology 
and patient populations vary, but there seems to be a trend to-
wards longer healing times with other modalities, such as 13 
weeks for scalp wounds with exposed bone with a simple wound 
care regimen of hydrogen peroxide and antibiotic ointment [5].
The use of ONE enables family members to perform dress-
ing changes simply and safely, indicating the potential for sig-
niﬁcant savings (at a cost of EUR 52 per week using ONE 
versus EUR 70 per week for secondary intention healing, or 
EUR 394.24 per week for healing with a collagen matrix fol-
lowed by grafting [9]). Comparison of costs among different 
health care systems is difﬁcult. However, it seems appropriate 
to use the ﬁgures of the German study by Inhoff et al. [9], as 
the health care systems and costs of living in Switzerland and 
Germany seem sufﬁciently similar, with costs in Switzerland 
being typically higher than in Germany. The trend shown in 
our ﬁgures with average total costs to healing using ONE of 
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